NFKB1 and colitis: It inhibited LPS-induced cytokine expression and NFκB nuclear translocation in peripheral blood mononuclear cells, decreased NFκB transcriptional activity while maintaining IκBα stability, and ameliorated trinitrobenzene sulfonic acid-induced colitis, indicating suppression of inflammation through NFκB inhibition [160] (Figure 6).